ACCEPTABILITY AND WRITING FREQUENCY OF ADVANCED DIRECTIVES IN ONCO-DERMATOLOGY PATIENTS

Study Overview
=================
Brief Summary
-----------------
The law about advance directives is evolving but, in France, few people write it. Te main endpoint of this research is to estimate the proportion of patients who have written their advance directives or considering doing so in onco-dermatologic population. If this rate remains low, some insights on the reasons will be able to be advanced looking at the point of view and opinion of patients about this topic. Seconds endpoints are : For patients against or not planning to write it, understand their reasons Estimate the proportion of patients requesting information and understand how they would like to receive it. Investigate a possible association between the stage of the oncological disease and the positioning of the patient concerning advance directives.

Official Title
-----------------
ACCEPTABILITY AND WRITING FREQUENCY OF ADVANCED DIRECTIVES IN ONCO-DERMATOLOGY PATIENTS

Conditions
-----------------
Advance Directives, Oncology, Skin Cancer, Melanoma, Skin Lymphoma, Skin Squamous Cell Carcinoma, Metastatic Basal Cell Carcinoma

Intervention / Treatment
-----------------
* Other: no intervention, only complete a survey


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: > 18 ya With one of the diagnoses below: Melanoma Skin lymphoma Meckel Carcinoma localy advanced or metastatic Basal cell carcinoma or squamous cell carcinoma Exclusion Criteria: Patients not in possession of all of its cognitive abilities Patients who can't read patients who don't speak french

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| patients accepting to answer to the survey<br>patients with a skin lymphoma OR melanoma OR advanced skin squamous cell carcinoma OR advanced basal cell carcinoma accepting to answer to the anonymous survey | Other: no intervention, only complete a survey<br>* we will ask patients to answer to a survey<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Writing by the patient of its advance directives | Writing by the patient of his advance directves and, if not writing, positioning of the patient (rather favorable or rather unfavorable) as to the writing of his advance directives. | when the patient complete the survey | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| reason for not writing advance directives | In patients who have not written their advance directives: reason for not writing the advance directives. | when the patient complete the survey | 
| Patient wishing to be more informed about the adavance directives during its management and, if so, by what means. |  | when the patient complete the survey | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
advance directives, Advance care planning, Patient's informed, treatment preferences, skin cancer, dermatology